semaglutide for perimenopause weight gain Review: 'The Drug Helped Me Lose 30 Pounds At Age 52' Compounded Semaglutide for Perimenopause |

1244-51 Hsieh, M.-J., et al., Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

Treatment discontinuations were higher, ranging from 12% to 17% of patients with semaglutide and 14% to 22% of patients with placebo, except in the STEP 4 study, which featured the 20-week run-in and where treatment discontinuations were 6% with semaglutide and 12% with placebo

A meta-analysis of 47 studies (randomised and non-randomised) found that glycine supplementation may be helpful for sleep and metabolic health at various doses from 6-15g per day

The most frequently reported AEs were diarrhea, COVID-19, nausea, and decreased appetite (12, 10, 7, and 6 events, respectively)